Cellular Biomedicine Group Inc (CBMG)

[tyler165]

3/23/10 Conference Call Notes

1. Cash flow and financials currently improved and expected to drastically improve in near future

2. Getting closer on Wonder and Tsingda they said, about 45 to 90 days until IPO for both, coin toss as to which will be first

3. Tsingda 2009 revenue of 14.6 million and 6.1 million net income (those are big numbers)

4. Tsingda probably will go AMEX with a natural migration to NYSE hopeful

5. Second amendment for Wonder to be filed hopefully this week

6. I liked the tone of Keith Wong when he was talking about how "the market will soon have to realize the value of EBIG stock....the value will be undeniable" (not exact words but tone and choice of words were very reassuring)

7. KaiDa moving slow on pre-audit work...still work in progress at this point...first time that KaiDa has had to prepare for external audit...basically they have to get their books straight before EBIG sends in audit team...80 million revenue and 10 million net income for KaiDa

8. Long's Gold...surveyors in Congo now, probably for about 2 months...long shot, but very good things could happen if large amounts of gold are found...currently looking into Chinese precious metal market for clients

9. 2 new clients on the horizon...will give more info when deals close

8. JKZ in NY this week...plans to merge into shell, like Tsingda...most likely will trade of OTCBB exchange...recently purchased phosphate mine

9. EBIG move to larger exchange discussed...most likely about a year away for this to happen but EBIG management likes the prospects for such a move...possible reverse stock split if needed to move to larger exchange

10. 6 hedge funds and investment banks putting up 25 million for Tsingda and Wonder...shows business models and growth prospects for both companies attractive to large investors...good thing, especially pre-IPO

11. EBIG management reiterrated that the expectation is that ALL clients are expected to go public via IPO...recent funding arrangements for Wonder and Tsingda are complementary, not in place of, any of EBIG's clients going public.